| REDISTRIBUTION i) England
In the late 1930s, health care in United Kingdom was funded by social security contributions, central taxation, local taxation, and voluntary contributions. Following the Beveridge Report in 1942, the political debate about the creation of a National Health Service agreed on the principle of universality. Seventy years later, the principle of free care for all that is funded principally with taxation remains. However, debate continues with tight expenditure controls and annual real increases in spending of less than 1% since 2010. This austerity has led to significant rationing of care with longer waiting times for elective procedures and has consequently led to conservatives advocating for funding alternatives such as charges or private insurance.
ii) United States
Although a minority in the United States advocates for universal care funded by a single payer, private employer-based insurance remains the bedrock mechanism. Unlike the United Kingdom and most Organisation for Economic Cooperation and Development (OECD) countries, the United States has never shown a political willingness to have government responsible for financial protection for all inhabitants against the cost of medical care. The United States has, however, accepted this responsibility for major components of society, namely, the aged, disabled, and low-income families and children (e.g., via Medicare, Medicaid, and the State Children's Health Insurance Program). This commitment was expanded with the Affordable Care Act (ACA) in 2010, commonly known as Obamacare.
These incremental efforts mean that the U.S. government currently pays close to 50% of health care expenditure (Centers for Medicare & Medicaid Services, 2015) , but the system is fragmented with variations in access to care and limited redistribution of financial burden. The ACA attempted to find a balance between expanded government financing and maintaining a vibrant private insurance market. Some wanted the government to take full responsibility for financing healthcare, whereas another minority believed government far over-reached. For most Americans, however, the key has been to find the right balance between government and the private sector.
iii) Summary
The outcomes of the two health care systems reflect a preference for collectivism in funding and access in the United Kingdom and for pluralism in funding (less third-party coverage) and a greater role for privately delivered care in the United States. But the battle continues in both countries as important groups advocate for the reversal of these preferences.
| REDESIGN
Policy makers continually try to change their health care systems. Some of these changes seek to develop greater efficiency in how care is delivered as a means of controlling the burdens imposed on society by ever-increasing public and private expenditure. Both countries face common problems that have been well identified for decades but have proven difficult to resolve.
Reformers face three common problems. First, unwarranted variations in clinical practice (Wennberg, 2008 , Wennberg, 2012 are produced by price variations in insurance systems and volume variations elsewhere (Institute of Medicine, 2013). Second, both systems have been slow to develop measures of the value of health care outcomes, that is, improvements in the length and quality of life. Third, both health care systems have perverse incentives that inhibit efficiency-inducing change; for example, they use hospital pricing or tariff systems that incentivise activity with little regard to patient value. Inadequate evaluation and political resistance to change continue to produce inefficiency. The end result is unnecessary spending and unethical deprivation of beneficial care for some populations.
The rest of this essay focuses on a more detailed discussion of: (a) efforts in England to limit public spending and improve the efficiency in the hospital sector, and (b) U.S. efforts to reduce the growth in the role of government in both the financing of care and how it is delivered.
i) England
The English single payer system is characterised by frugality and cycles of famine and plenty, with attendant bouts of supply side reform (Street & Maynard, 2007) . Constrained funding in the 1980s led to the Thatcher reforms and the creation of the "quasimarket" of purchaser and providers contracting for public and private care. These structural reforms received increased funding in the early 1990s. By the end of the 1990s, financial parsimony was creating renewed performance problems, for example, increased waiting times for elective surgery. As a consequence, the Blair government financed a large increase in funding. Since 2010, the Coalition and now Conservative government has exerted extreme expenditure controls, and current plans will result in real per capita funding falling by 2018.
Since the Thatcher era, the often violent fluctuations in NHS funding have been accompanied by the "redisorganisation" of structures and processes of care whilst maintaining universal cover age free at the point of use. The purchaser side of the National Health Service (NHS) market has evolved from health authorities to primary care trusts and now to clinical commissioning groups, all with similar functions and uncertain impact. The provider side of the market remains dominated by public institutions as private providers have made only marginal inroads to public funding.
The current chronic underfunding of the NHS and social care, manifested currently by increased waiting times for elective procedures, has produced inevitable pursuit of the "Holy Grail" of increased productivity. The Five Year Forward View (NHS, 2014) involved the acceptance of government parsimony and for the 2015-2020 period. Its authors argued that the NHS would require £30 billion to meet demographic and technological demands, of which only £8 billion was to be provided from tax revenues. The additional £22 billion was to be funded from productivity increases. Current NHS spending is £110 billion.
Currently, a frenzy of structural reform proposals range from integration of currently fragmented hospital, primary and social care systems to hospital mergers to the abolition of the purchaser-provider "market" with the creation of accountable care organisations. These proposals involve unevidenced merger plans and deskilling of nursing and other workforce changes. The Sustainability and Transformation Plans (https://www.england.nhs.uk/stps/) are radical but unlikely to yield £22 billion of productivity gains in 5 years. There is little available funding to finance the change process, and its duration is likely to take many years to free up resources.
In common with many other public sector functions in England, the NHS and social care are on a knife edge (Maynard, 2017) . Politicians continue to assert that the NHS will survive past its 70th anniversary next year. But with government fixated with austerity and mesmerised by Brexit, survival is uncertain.
ii) United States
Among the critics of the ACA who believe the legislation expanded the role of government too much, three components of the ACA stand out for possible repeal:
• a mandate that everyone must have or buy insurance;
• an expansion of those who qualify for total government coverage through the combined federal/state Medicaid program; and • a requirement that all acceptable insurance include an expanded list of essential benefits and illnesses that must be covered (e.g., expanded benefits for the mentally ill or those with substance abuse problems and the inclusion of all forms of contraceptives as preventive care with no copayments).
This essay cannot do justice to what became a major political and substantive debate in early 2017 as to what programs should replace the ACA. Even under the best of possibilities put forward, a substantial proportion of those covered under provisions of the ACA would again become uninsured, and the medical conditions that the ACA required must be covered in an insurance policy that receives a federal subsidy would be reduced. In addition, much criticism has been levelled against the ACA for doing too little to control the high cost of medical care, which is now growing at more than 5% per year and exceeds $3.0 trillion (18% of U.S. gross domestic product). Two programs discussed as part of the "replacement" package that focuses on limiting the growth in healthcare expenditures include:
• having more Americans buy high deductible insurance so that they have a financial incentive not to use overly expensive or questionably useful care; and • a requirement that private insurance be sold across state lines (currently, states can limit the types of private insurance sold in its jurisdiction and what benefits such insurance must cover).
Both options assume that healthcare is much more expensive in the United States than in any OECD country because American patients use too much medical care. Yet the evidence does not support this assumption. Americans are less likely to be admitted to a hospital and have a lower length of stay once in a hospital than many OECD countries. Americans also are less likely to see a doctor or use fewer pharmaceuticals than patients in OECD countries. U.S. patients do use more very expensive medical devices such as MRIs or new and expensive drugs, but on net, the pluses and minus may cancel out. What separates United States spending from that in OECD countries are the prices charged for all medical activities. The reasons for the higher prices are complicated and due to a myriad of factors including the higher wages paid to most participants in the healthcare system (not only physicians); the much higher prices Americans pay for drugs and medical devices; and the fact that the complexity of the U.S. system has evolved in a way that requires the use of many more lawyers, consultants, and administrators, all of whom are well paid. The latter consideration is possibly more central because some key providers such as primary care physicians receive relatively low compensation relative to education costs and work conditions. Additional efforts within the United States that are sometimes related to the ACA include a broad interest in insurance redesign, emphasis on value from services provided, and a focus on patient-centred outcomes. Value-based cost-sharing approaches are being implemented in the United States as well as other OECD countries (Thomson, Schang, & Chernew, 2013) , though these approaches are more easily implemented for certain services such as pharmaceuticals. The Medicare program is testing a number of value-based payment innovations and incentive payments. The Patient-Centered Outcomes Research Institute is a nongovernmental institute created under ACA that was charged with assessing the effectiveness and appropriateness of medical treatments. However, the Patient-Centered Outcomes Research Institute is not able to mandate coverage or reimbursement for any treatments and infamously is prohibited from considering cost per quality-adjusted life years in its recommendations despite widespread interest in this measure in many other countries.
| CONCLUSIONS
The American and the English health and social care systems differ greatly, but they are surprisingly similar in some dimensions. Key differences pertain to who pays for care and how it is delivered, with the United States having a more decentralized and fragmented system leading to inequalities in the provision of care and its funding. The English system is universal and largely free at the point of consumption system but constrained by limited funding (which also generates inequalities in access to timely care).
